Ad is loading...
NTLA
Price
$13.97
Change
-$1.15 (-7.61%)
Updated
Nov 15 closing price
95 days until earnings call
QSI
Price
$0.73
Change
-$0.05 (-6.41%)
Updated
Nov 15 closing price
101 days until earnings call
Ad is loading...

NTLA vs QSI

Header iconNTLA vs QSI Comparison
Open Charts NTLA vs QSIBanner chart's image
Intellia Therapeutics
Price$13.97
Change-$1.15 (-7.61%)
Volume$3.69M
CapitalizationN/A
Quantum-Si
Price$0.73
Change-$0.05 (-6.41%)
Volume$697.55K
CapitalizationN/A
NTLA vs QSI Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NTLA vs. QSI commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongSell and QSI is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NTLA: $13.97 vs. QSI: $0.73)
Brand notoriety: NTLA and QSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 159% vs. QSI: 131%
Market capitalization -- NTLA: $1.42B vs. QSI: $104.54M
NTLA [@Biotechnology] is valued at $1.42B. QSI’s [@Biotechnology] market capitalization is $104.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both NTLA and QSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while QSI’s TA Score has 2 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 4 bearish.
  • QSI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than QSI.

Price Growth

NTLA (@Biotechnology) experienced а -16.50% price change this week, while QSI (@Biotechnology) price change was -21.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

QSI is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.42B) has a higher market cap than QSI($105M). NTLA YTD gains are higher at: -54.182 vs. QSI (-63.468). QSI has higher annual earnings (EBITDA): -84.95M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. QSI (218M). QSI has less debt than NTLA: QSI (13.6M) vs NTLA (106M). NTLA has higher revenues than QSI: NTLA (46M) vs QSI (1.7M).
NTLAQSINTLA / QSI
Capitalization1.42B105M1,355%
EBITDA-514.18M-84.95M605%
Gain YTD-54.182-63.46885%
P/E RatioN/AN/A-
Revenue46M1.7M2,703%
Total Cash691M218M317%
Total Debt106M13.6M779%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAQSI
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TYCMY28.210.43
+1.55%
Tingyi Cayman Islands Holdings Corp.
DBSDF33.090.40
+1.22%
DBS Group Holdings Ltd.
NPSCY6.570.03
+0.43%
Nippon Steel Corporation
NVNXF0.51-0.02
-3.87%
NOVONIX Ltd.
RSNVF0.09N/A
-4.54%
Reyna Silver Corp.

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-7.61%
VCYT - NTLA
69%
Closely correlated
-2.97%
EDIT - NTLA
68%
Closely correlated
-3.97%
BEAM - NTLA
67%
Closely correlated
-8.59%
CRSP - NTLA
64%
Loosely correlated
+0.85%
PRME - NTLA
58%
Loosely correlated
-6.95%
More